Table 2.
Clinical and biochemical characteristics of the systemic lupus erythematosus stratified according to the body mass index (BMI).
| Variable | BMI < 25 kg/m2 (n = 39) | BMI > 25 kg/m2 (n = 91) | p Value |
|---|---|---|---|
| Age (years) a | 35.10 ± 1.72 | 42.26 ± 1.30 | 0.999 |
| Mex-SLEDAI c | 0 (0–6) | 2 (0–10) | 0.003 |
| Mex-SLEDAI % (n) | 0.039 | ||
| Remission (<2) b | 78.4 (29/37) | 59.1 (52/88) | |
| Activity (≥2) b | 21.6 (8/37) | 40.9 (36/88) | |
| Blood pressure | |||
| Systolic (mmHg) c | 110 (90–139) | 113 (100–143) | 0.028 |
| Diastolic (mmHg) c | 71.5 (60–90) | 77 (64–97) | 0.043 |
| Blood pressure (SBP/DBP mmHg) % (n) | 0.354 | ||
| Normal (<130/<85) b | 82.1 (23/28) | 61.3 (19/31) | |
| Normal high (130–139/85–89) b | 10.7 (3/28) | 16.1 (5/31) | |
| AH systolic (140–149/<90) b | 7.1 (2/28) | 12.9 (4/31) | |
| AH grade 1 (140–159/90–99) b | 0 (0/28) | 6.4 (2/31) | |
| AH grade 2 (160–179/100–109) b | 0 (0/28) | 0 (0/31) | |
| AH grade 3 (≥180/≥110) b | 0 (0/28) | 3.2 (1/31) | |
| Glucose (mg/dL) | 85.55 (65.82–98.76) | 90.08 (70.4–132.95) | 0.045 |
| Glucose classification (% n) | 0.006 | ||
| Normal (<100 mg/dL) b | 97.1 (34/35) | 71.1 (59/83) | |
| Prediabetes (100–125 mg/dL) b | 2.9 (1/35) | 20.5 (17/83) | |
| Diabetes (>126 mg/dL) b | 0 (0/35) | 8.4 (7/83) | |
| Lipid profile | |||
| Triglycerides (mg/dL) c | 98.42 (45.5–168.6) | 125.7 (57.7–260.6) | 0.0007 |
| Total Cholesterol (mg/dL )c | 159.5 (112–240.7) | 175 (117.02–250.8) | 0.077 |
| LDL-C (mg/dL) c | 79.74 (47.85–128.7) | 72.4 (41.3–130.7) | 0.215 |
| HDL-C (mg/dL) c | 38.2 (15.94–66.7) | 25.8 (12.8–54.4) | 0.0009 |
a Data provided in average ± standard deviation, Student’s t-test. b Data provided in percentages (n/total patients evaluated), χ2 test. c Data provided in median (percentile: p5th–p95th), Mann–Whitney test. AH: arterial hypertension. The bold letters indicate the variables with significant differences.